Effects of antipsychotics on the serum BDNF levels in schizophrenia

Psychiatry Research

Volumn 189, Issue 3, 2011, Pages 327-330

  Chen, Chien Chih ^a   Huang, Tiao Lai ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Atypical antipsychotics; Brain derived neurotrophic factor (BDNF); Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CHLORPROMAZINE; CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG MECHANISM; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARANOID SCHIZOPHRENIA; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELAPSE; SCHIZOPHRENIA; SEX RATIO; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CLOZAPINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; RISPERIDONE; SCHIZOPHRENIA, PARANOID;

EID: 80051788845     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.01.011     Document Type: Article

References (33)

1. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., Lindsay R.M., Wiegand S.J. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997, 389:856-860.
2. Angelucci F., Mathe A.A., Aloe L. Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. Journal of Neuroscience Research 2000, 60:783-794.
3. Arranz M.J., de Leon J. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Molecular Psychiatry 2007, 12:707-747.
4. Ashe P.C., Berry M.D., Boulton A.A. Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Progress in Neuropsychopharmacology & Biological Psychiatry 2001, 25:691-707.
5. Bai O., Chlan-Fourney J., Bowen R., Keegan D., Li X.M. Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. Journal of Neuroscience Research 2003, 71:127-131.
6. Chlan-Fourney J., Ashe P., Nylen K., Juorio A.V., Li X.M. Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration. Brain Research 2002, 954:11-20.
7. Frost D.O., Tamminga C.A., Medoff D.R., Caviness V., Innocenti G., Carpenter W.T. Neuroplasticity and schizophrenia. Biological Psychiatry 2004, 56:540-543.
8. Grillo R.W., Ottoni G.L., Leke R., Souza D.O., Portela L.V., Lara D.R. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. Journal of Psychiatric Research 2007, 41:31-35.
9. Gustafsson G., Lira C.M., Johansson J., Wisen A., Wohlfart B., Ekman R., Westrin A. The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder. Psychiatry Research 2009, 169:244-248.
10. Huang T.L., Lee C.T. Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients. Journal of Psychiatric Research 2006, 40:664-668.
11. Huang T.L., Lee C.T. Associations between brain-derived neurotrophic factor G196A gene polymorphism and clinical phenotypes in schizophrenia patients. Chang Gung Medical Journal 2007, 30:408-413.
12. Ikeda Y., Yahata N., Ito I., Nagano M., Toyota T., Yoshikawa T., Okubo Y., Suzuki H. Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia. Schizophrenia Research 2008, 101:58-66.
13. Karege F., Schwald M., Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neuroscience Letters 2002, 328:261-264.
14. Kay S.R., Opler L.A., Lindenmayer J.P. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. The British Journal of Psychiatry. Supplement 1989, 59-67.
15. Kim T.S., Kim D.J., Lee H., Kim Y.K. Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation. Neuroscience Letters 2007, 423:53-57.
16. Linden A.M., Vaisanen J., Lakso M., Nawa H., Wong G., Castren E. Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotrophic agents. Journal of Molecular Neuroscience 2000, 14:27-37.
17. Lipska B.K., Khaing Z.Z., Weickert C.S., Weinberger D.R. BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs. The European Journal of Neuroscience 2001, 14:135-144.
18. Lommatzsch M., Zingler D., Schuhbaeck K., Schloetcke K., Zingler C., Schuff-Werner P., Virchow J.C. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiology of Aging 2005, 26:115-123.
19. Nawa H., Takahashi M., Patterson P.H. Cytokine and growth factor involvement in schizophrenia-support for the developmental model. Molecular Psychiatry 2000, 5:594-603.
20. Pirildar S., Gonul A.S., Taneli F., Akdeniz F. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Progress in Neuropsychopharmacology & Biological Psychiatry 2004, 28:709-713.
21. Rizos E.N., Rontos I., Laskos E., Arsenis G., Michalopoulou P.G., Vasilopoulos D., Gournellis R., Lykouras L. Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Progress in Neuropsychopharmacology & Biological Psychiatry 2008, 32:1308-1311.
22. Rizos E.N., Papadopoulou A., Laskos E., Michalopoulou P.G., Kastania A., Vasilopoulos D., Katsafouros K., Lykouras L. Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. The World Journal of Biological Psychiatry 2010, 11:251-255.
23. Shimizu E., Hashimoto K., Watanabe H., Komatsu N., Okamura N., Koike K., Shinoda N., Nakazato M., Kumakiri C., Okada S., Iyo M. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neuroscience Letters 2003, 351:111-114.
24. Shoval G., Weizman A. The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. European Neuropsychopharmacology 2005, 15:319-329.
25. Tan Y.L., Zhou D.F., Cao L.Y., Zou Y.Z., Zhang X.Y. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Neuroscience Letters 2005, 382:27-32.
26. Toyooka K., Asama K., Watanabe Y., Muratake T., Takahashi M., Someya T., Nawa H. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Research 2002, 110:249-257.
27. Verhagen M., van der Meij A., van Deurzen P.A., Janzing J.G., Arias-Vasquez A., Buitelaar J.K., Franke B. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Molecular Psychiatry 2010, 15:260-271.
28. Webster M.J., Herman M.M., Kleinman J.E., Shannon Weickert C. BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. Gene Expression Patterns 2006, 6:941-951.
29. Weinberger D.R. From neuropathology to neurodevelopment. Lancet 1995, 346:552-557.
30. Xiu M.H., Hui L., Dang Y.F., Hou T.D., Zhang C.X., Zheng Y.L., Chen da C., Kosten T.R., Zhang X.Y. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics. Progress in Neuropsychopharmacology & Biological Psychiatry 2009, 33:1508-1512.
31. Yoshimura R., Hori H., Sugita A., Ueda N., Kakihara S., Umene W., Nakano Y., Shinkai K., Mitoma M., Ohta M., Shinkai T., Nakamura J. Treatment with risperidone for 4weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients. Progress in Neuropsychopharmacology & Biological Psychiatry 2007, 31:1072-1077.
32. Yoshimura R., Ueda N., Hori H., Ikenouchi-Sugita A., Umene-Nakano W., Nakamura J. Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients. The World Journal of Biological Psychiatry 2010, 11:256-261.
33. Zhang X.Y., Tan Y.L., Zhou D.F., Cao L.Y., Wu G.Y., Xu Q., Shen Y., Haile C.N., Kosten T.A., Kosten T.R. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics. Journal of Psychiatric Research 2007, 41:997-1004.